Cromolyn Sodium differentially regulates human mast cell and mouse leukocyte responses to control allergic inflammation-Reference-Cited by-同舟云学术

Cromolyn Sodium differentially regulates human mast cell and mouse leukocyte responses to control allergic inflammation

Published:2022-04 Issue: Volume:178 Page:106172
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Puzzovio Pier Giorgio,Brüggemann Thayse R.,Pahima Hadas,Mankuta David,Levy Bruce D.,Levi-Schaffer Francesca

Funder

United States Israel Binational Science Foundation

Publisher

Elsevier BV

Subject

Pharmacology

Reference56 articles.

1. Disodium cromoglycate (FPL 670) (‘Intal’*): a specific inhibitor of reaginic antibody–antigen mechanisms;Cox;Nature,1967

2. Nature and modes of action of disodium cromoglycate (Lomudal®);Cox;Respiration,1970

3. Development of preclinical models for testing antiasthma drugs;Orr;Drugs,1989

4. Anti-allergic cromones inhibit histamine and eicosanoid release from activated human and murine mast cells by releasing Annexin A1;Yazid;PLoS One,2013

5. Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine;Okayama;Clin. Exp. Allergy,1992

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mast cells and the gut-liver Axis: Implications for liver disease progression and therapy;Life Sciences;2024-08

2. Discovery of novel osthole derivatives exerting anti-inflammatory effect on DSS-induced ulcerative colitis and LPS-induced acute lung injury in mice;European Journal of Medicinal Chemistry;2024-03

3. Luteolin Is More Potent than Cromolyn in Their Ability to Inhibit Mediator Release from Cultured Human Mast Cells;International Archives of Allergy and Immunology;2024

4. GPR35 inhibits TRPA1-mediated colonic afferent hypersensitivity through suppression of Substance P release;2023-09-15

5. Mast cell silencing: A novel therapeutic approach for urticaria and other mast cell‐mediated diseases;Allergy;2023-08-22